BPC-157 + TB-500 Blend

What Is the BPC-157 + TB-500 Blend?

This blend combines two of the most widely researched healing peptides into a single pre-mixed vial. BPC-157 (Body Protection Compound) is a gastric peptide that promotes localized tissue repair, particularly in tendons, ligaments, and the GI tract. TB-500 is a synthetic fragment of Thymosin Beta-4 that works systemically to reduce inflammation and accelerate tissue regeneration throughout the body.

By combining both peptides, the blend provides dual-mechanism healing coverage: BPC-157 concentrates repair activity near the injection site while TB-500 distributes systemically to reach injuries wherever they occur. This eliminates the need to reconstitute and dose two separate vials.

Mechanism of Action

The blend leverages two distinct but complementary healing pathways that work in parallel.

BPC-157 Pathways

• Nitric Oxide Modulation: Regulates NO signaling to promote blood vessel formation and protect endothelial tissue at injury sites.
• Growth Factor Upregulation: Increases local expression of VEGF, EGF, and other growth factors that drive tendon, ligament, and mucosal repair.
• GI Protection: Exerts cytoprotective effects on gastric and intestinal mucosa, supporting gut barrier integrity.

TB-500 Pathways

• Actin Regulation: Upregulates G-actin to promote cell migration and new tissue formation at injury sites body-wide.
• Anti-Inflammatory: Downregulates inflammatory cytokines systemically, reducing swelling across multiple injury sites simultaneously.
• Angiogenesis: Stimulates new blood vessel growth into damaged tissue for improved oxygen and nutrient delivery during recovery.

Research Applications

Multi-Site Injury Recovery

The blend is particularly suited for subjects with injuries in multiple areas. TB-500’s systemic reach covers the entire body while BPC-157 provides concentrated repair at the injection site, offering broader healing coverage than either peptide alone.

Post-Surgical Recovery

Researchers studying post-operative healing use this combination for its dual action: BPC-157’s localized tissue repair at the surgical site paired with TB-500’s body-wide anti-inflammatory and cell migration properties.

Chronic Tendon and Joint Issues

For persistent tendinopathy, joint inflammation, or connective tissue degradation, the blend provides both immediate localized support and ongoing systemic repair signaling over extended protocols.

Gut + Musculoskeletal

Subjects with concurrent GI issues and musculoskeletal injuries benefit from BPC-157’s gastroprotective effects alongside TB-500’s structural tissue repair, addressing both systems in a single injection.

Dosing Protocol

Because the blend is pre-mixed, dosing is simplified compared to running both peptides separately. Protocols vary based on the ratio and total peptide content per vial.

Preparation & Storage

Reconstitution

Supplies: peptide vial, bacteriostatic water, insulin syringes (29–31 gauge), alcohol swabs.

1. Clean both vial tops with alcohol swabs and let dry
2. Draw 2 mL of bacteriostatic water into the syringe
3. Insert needle into peptide vial at an angle against the glass wall
4. Let water run slowly down the side – never squirt directly onto powder
5. Gently swirl until fully dissolved – never shake
6. Solution should be clear – discard if cloudy or contains particles

Storage

• Unreconstituted: Room temp or refrigerated, stable up to 24 months
• Reconstituted: Refrigerate at 2–8°C (36–46°F), use within 4–6 weeks
• Protect from direct sunlight and heat
• Do not freeze reconstituted solution

Cycling

Typical research cycle: 4–8 weeks. Results generally reported within 1–2 weeks.